Connect with us

Press Release

Manitoba Woman Beats Stage 4 Cancer with Breakthrough CAR T-Cell Therapy

Published

5 months ago

on

–News Direct–

Source: Pexels
Source: Pexels

Disseminated on behalf of CERo Therapeutics Holdings, Inc.

Cancer treatments have come a long way over the years, but there is a newer treatment that is providing even stage four cancer patients with a new lease on life.

The first CAR T-cell therapy was only approved in 2017, but its already having a significant impact in the cancer treatment market. The latest success story comes from Sandra Hajlo, who just became the first person in Manitoba to be declared cancer-free following CAR T-cell therapy.1

Initially diagnosed with stage four B-cell lymphoma in 2015, Hajlo underwent successful chemotherapy. However, eight years later, her cancer returned, leading to another battle with the disease. After a misdiagnosis of scoliosis, a CT scan revealed her cancer had come back.

Her oncologist recommended CAR T-cell therapy, a new treatment where T-cells are modified to target cancer cells, making her the first recipient of this therapy at CancerCare Manitoba.

Dr. David Szwajcer, Manitoba Blood & Marrow Transplant Director at CancerCare Manitoba, explained that the CAR T-cells are collected, sent to a U.S. facility for modification, and then reintroduced to the patient. Hajlo described the procedure as quick and straightforward, taking only 20 minutes.

After undergoing CAR T-cell therapy in December 2023, Hajlo learned in April 2024 that the treatment was successful, and she is cancer-free once again, expressing her gratitude for the second chance at life.

CAR T-cell therapy does not guarantee survival, with about half of the patients not responding,but it has shown promising results in many cases.

CERo Therapeutics Holdings (NASDAQ:CERO) is an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics. CERo Therapeutics is unrelated to CancerCare Manitoba and had no role in the CAR T-cell therapy described above. Nevertheless, CERo Therapeutics believes that the success of the CAR T-cell therapy in Manitoba may provide an indication of the potential for its proprietary CER-T (chimeric engulfment receptor) cell therapy.

CAR-T cell treatment has a steep price tag and some potential serious side effects including secondary cancer developing2 as well as cytokine release syndrome (CRS),3 which causes your immune system to go into overdrive and is potentially life threatening. CER-T cell therapy may provide a more cost-effective alternative with fewer side effects.

CERo Advances Innovative Cancer Immunotherapy

CERo Therapeutics (NASDAQ:CERO) developed CER-T cells to enhance efficiency and reduce side effects compared to traditional therapies by leveraging the body's natural tumor-fighting mechanisms. CER-T cells achieve this through direct tumor killing and by amplifying the body's anti-tumor immune response, and additionally by presenting cancer cell fragments to other immune cells, drawing these cells to attack the tumor.

Peer-reviewed data shows that CER-T cells have at least eight anticancer functions, offering potent, durable, and low-toxicity therapeutic benefits, with the capability to completely eliminate tumors. The company has validated these findings in 10 animal experiments, including a study on Acute Myeloid Leukemia (AML) published in March 2024.

CERo Therapeutics believes CER-T cells offer greater therapeutic potential than currently approved chimeric antigen receptor (CAR-T) cell therapy, potentially targeting both hematological malignancies and solid tumors. The company plans to begin clinical trials for its lead product candidate, CER-1236, in 2024 for treating hematological malignancies.

CERo has been diligently completing pre-clinical studies and documentation necessary to initiate clinical trials after gaining approval from the FDA for its Investigational New Drug (IND) Application.

CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) has successfully completed toxicity studies for CER-1236, a critical step before applying to the FDA for approval to begin human trials. With these studies showing that CER-1236 can be safely administered, the company is now focusing on ensuring safe manufacturing and finalizing its FDA application. Upon FDA acceptance, the company would be able to commence Phase 1 clinical trials, marking the start of the journey toward US approval and addressing unmet medical needs.

CERo plans to update shareholders on their progress, including presentations at investor conferences, potential growth of their intellectual property portfolio, and advancements in other programs beyond AML.

Click here for more information CERo Therapeutics Holdings, Inc., (NASDAQ:CERO).

Footnotes:

[1] https://globalnews.ca/news/10428035/manitobas-first-car-t-cell-therapy-patient-declared-cancer-free/

[2] https://jamanetwork.com/journals/jama/article-abstract/2815500

[3] https://www.pennmedicine.org/cancer/navigating-cancer-care/treatment-types/immunotherapy/what-is-car-t-therapy

Disclosure:

1) The author of the Article, or members of the authors immediate household or family, do not own any securities of the companies outlined in this Article. The author determined which companies would be included in this article based on research and understanding of the sector.

2) The Article was issued on behalf of and sponsored by, CERo Therapeutics Holdings, Inc. Market Jar Media Inc. was paid $1,500 USD for the production and publishing of this article by CERo Therapeutics Holdings, Inc.s Digital Marketing Agency of Record (Native Ads Inc.). Additional details relating to Market Jar Media Inc.s engagement by CERo Therapeutics Holdings, Inc.s Digital Marketing Agency of Record (Native Ads Inc.) are set out in https://pressreach.com/disclaimer-cero.

3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. Market Jar has not independently verified or otherwise investigated all such information. None of Market Jar or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. All investments carry risk and each reader is encouraged to consult with his or her individual financial professional. Any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on PressReach.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on PressReach.com.

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.

6) This communication contains statements that are forward-looking and as such are not historical facts. This includes, without limitation, statements regarding the financial position, business strategy and the plans and objectives of management for future operations of CERo. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this communication, words such as anticipate, believe, continue, could, estimate, expect, intend, may, might, plan, possible, potential, predict, project, should, strive, would and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. When CERo discusses its strategies or plans, it is making projections, forecasts or forward-looking statements. Such statements are based on the beliefs of, as well as assumptions made by and information currently available to, CERos management. Actual results could differ from those implied by the forward-looking statements in this communication. Certain risks that could cause actual results to differ are set forth in CERos filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K, filed on April 2, 2024, and the documents incorporated by reference therein. The risks described in CERos filings with the Securities and Exchange Commission are not exhaustive. New risk factors emerge from time to time and it is not possible to predict all such risk factors, nor can CERo assess the impact of all such risk factors on its business, or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements, which speak only as of the date hereof. All forward-looking statements made by CERo or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements. CERo undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

7) Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of CERo Therapeutics Holdings, Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of CERo Therapeutics Holdings, Inc. or such entities and are not necessarily indicative of future performance of CERo Therapeutics Holdings, Inc. or such entities.

8) Investing is risky. The information provided in this article should not be considered as a substitute for professional financial consultation. Users should be aware that investing in any form carries inherent risks, and as such, there is a possibility of losing some or all of their investment. The value of investments can fluctuate significantly within a short period, and investors must understand that past performance is not indicative of future results. Additionally, users should exercise caution as transactions involving investments may be irreversible, even in cases of fraud or accidental actions. It is crucial to acknowledge that rapidly evolving laws and technical issues can have adverse effects on the usability, transferability, exchangeability, and value of investments. Furthermore, users must be cognizant of potential security risks associated with their investment activities. Individuals are strongly encouraged to conduct thorough research, seek professional advice, and carefully evaluate their risk tolerance before engaging in any investment endeavors. Market Jar Media Inc. is neither an investment adviser nor a broker-dealer. The information presented on the website is provided for informative purposes only and is not to be treated as a recommendation to make any specific investment. No such information on PressReach.com constitutes advice or a recommendation.

Contact Details

James Young

+1 800-340-9767

campaigns@pressreach.com

Company Website

https://pressreach.com

View source version on newsdirect.com: https://newsdirect.com/news/manitoba-woman-beats-stage-4-cancer-with-breakthrough-car-t-cell-therapy-472550199

MarketJar

comtex tracking

COMTEX_453434643/2655/2024-06-06T08:32:55

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Related Topics:
Continue Reading

Press Release

ExpressPara.ma: Morocco’s Leading Parapharmacie en Ligne Expands with Top Beauty Brands

Published

2 hours ago

on

October 23, 2024

By

ExpressPara.ma, Morocco’s top parapharmacie en-ligne, has expanded its online platform to offer a wider range of globally recognized healthcare and skincare brands, including CeraVe, La Roche-Posay, Perfectil, and Eucerin. The platform provides Moroccan customers with easy access to pharmaceutical-grade products and expert advice through a seamless shopping experience. With fast delivery, secure payment options, and personalized support, ExpressPara.ma is committed to bringing the best in beauty and healthcare to homes across Morocco. Visit www.expresspara.ma to explore their full product range.

Morocco, 23rd Oct 2024 – ExpressPara, a leading online parapharmacy in Morocco, proudly announces the launch of its expanded platform, offering a comprehensive selection of high-quality healthcare, skincare, and wellness products. The newly enhanced range includes essential items such as sunscreens, cleansers, moisturizers, and more, featuring trusted global brands like CeraVe, La Roche-Posay, and Eucerin. With a strong focus on accessibility, personalized customer care, and cutting-edge products, ExpressPara.ma is poised to become the go-to destination for Moroccan consumers seeking reliable brands and expert advice—all from the comfort of their homes.

A One-Stop Shop for Health and Wellness

ExpressPara.ma provides Moroccan customers with access to a curated selection of pharmaceutical-grade skincare products, dietary supplements, personal care items, and more. With over 8,000 products available online, the platform features internationally renowned brands such as La Roche-Posay, Eucerin, Bioderma, and CeraVe, ensuring that customers can find the best solutions for their health and well-being.

“We are excited to bring ExpressPara.ma to life and offer Moroccan customers a parapharmacy experience that is both comprehensive and convenient,” said Mr Anwar Khalil, CEO of ExpressPara.ma. “Our goal is to help customers make informed choices about their healthcare needs, with the assurance that they are purchasing authentic, high-quality products.”

A Commitment to Customer Service and Convenience

ExpressPara.ma is not just about offering products; it is about delivering an excellent customer experience. With fast delivery, easy-to-navigate categories, and expert advice available through its website, the company aims to provide the highest level of service for online shoppers.

Customers can easily find products tailored to their needs, thanks to detailed product descriptions, user-friendly filters, and a powerful search bar integrated into the website. ExpressPara.ma also offers free consultations with certified pharmacists, allowing users to make well-informed decisions regarding their purchases.

Innovative Technology and Seamless Shopping Experience

ExpressPara.ma stands out by integrating cutting-edge technology into its platform. With auto-sync features, high SEO ranking, and direct integration with its ERP system, the platform ensures that customers always have access to the latest products and real-time stock availability. Additionally, ExpressPara.ma uses a smooth checkout process and secure payment options to enhance the overall shopping experience.

Expanding Access to Trusted Brands in Morocco

As part of its mission to become the leading online parapharmacy in Morocco, ExpressPara.ma is continuously expanding its partnerships with top skincare and healthcare brands. The company is also working to establish a collaboration with CeraVe , one of the most trusted skincare brands globally, allowing customers to easily purchase CeraVe products through its website.

About ExpressPara.ma

ExpressPara.ma is a Moroccan-based online parapharmacy that provides customers with access to a wide range of skincare, health, and wellness products. With a commitment to offering top-tier service, ExpressPara.ma combines innovation with customer care to create a seamless online shopping experience. The platform is dedicated to delivering authentic products, expert advice, and fast delivery across Morocco.

Media Contact

Organization: Expresspara

Contact Person: Anwar

Website: https://expresspara.ma

Email: Send Email

Country: Morocco

Release Id: 23102418891

The post ExpressPara.ma: Morocco’s Leading Parapharmacie en Ligne Expands with Top Beauty Brands appeared on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it.

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Beavod Announces Innovative Airdrop Mechanism on Telegram

Published

3 hours ago

on

October 23, 2024

By

Beavod, a blockchain gaming platform, has launched a new airdrop mechanism on Telegram that encourages users to collect WOOD tokens by completing weekly tasks. The WOOD tokens accumulated will influence the VOD token rewards distributed the following week, promoting ongoing participation and engagement. The platform continues to expand its game offerings and integrate new features like NFTs to enhance the user experience. Beavod also has plans for global expansion and listing its VOD token on major exchanges to increase its liquidity and market value.

Wood to Wealth
Expanding Opportunities in Blockchain Gaming

Beavod, a blockchain gaming platform, has announced the launch of a new airdrop mechanism aimed at enhancing user engagement through simple weekly activities. This new initiative will be rolled out on Telegram, where participants can collect WOOD tokens by completing specific tasks. WOOD, the platform’s core resource, will play a key role in determining the distribution of VOD tokens, offering rewards based on user participation.

New Developments and Airdrop Introduction

Beavod’s latest feature emphasizes its commitment to fostering a dynamic, decentralized gaming environment. The platform’s new airdrop system allows participants to collect WOOD tokens by engaging with the platform’s weekly activities. This initiative aligns with Beavod’s broader goal of making blockchain technology more accessible to a wider audience while ensuring that active users are rewarded for their contributions.

This WOOD-to-VOD reward structure reflects Beavod’s mission to build a sustainable and transparent ecosystem for its growing community. The more WOOD tokens a player collects within a given week, the more VOD tokens they will receive the following week, highlighting the platform’s focus on activity-driven rewards.

Key Features of the Airdrop Mechanism

  • Weekly Participation: The airdrop mechanism encourages users to take part in weekly tasks, including watching ads or completing in-game objectives, to collect WOOD tokens.
  • WOOD-to-VOD System: The amount of WOOD tokens collected each week will directly influence the quantity of VOD tokens distributed in the subsequent week, creating a structured and predictable reward process.
  • Fair and Transparent Distribution: Utilizing decentralized blockchain technology, the airdrop ensures that all rewards are distributed in a fully traceable and fair manner.

Platform Growth and Future Plans

Beavod continues to expand its game library with the introduction of 2-3 new titles each month, offering users a diverse range of gaming experiences. Future updates include the integration of NFT functionality, allowing players to acquire and trade unique in-game assets, further enriching Beavod’s ecosystem.

The WOOD token, which serves as the platform’s core resource, is designed to encourage regular engagement, while the VOD token distribution will provide users with additional opportunities within the Beavod ecosystem. These developments reflect Beavod’s dedication to continually improving the platform and offering users new opportunities to engage with blockchain technology.

Global Expansion and Long-Term Vision

Beavod’s long-term strategy includes expanding its reach across international markets through community engagement programs and enhanced language support. Over the next two years, Beavod plans to list the VOD token on major exchanges, which will increase its liquidity and value, helping to position Beavod as a leader in the blockchain gaming space.

About Beavod

Beavod is a blockchain-based gaming platform focused on creating a decentralized and sustainable ecosystem. The platform integrates blockchain technology with an ever-growing library of games to offer users a seamless and engaging experience.

Stay connected:

Media Contact

Organization: Beavod ltd

Contact Person: BeaverASK

Website: https://www.beavod.world/

Email: Send Email

Country: Singapore

Release Id: 23102418804

The post Beavod Announces Innovative Airdrop Mechanism on Telegram appeared on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it.

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Eagle Likes Launches Cutting-Edge Social Media Growth Services to Boost Online Visibility for Content Creators and Businesses

Published

3 hours ago

on

October 23, 2024

By

United States, 23rd Oct 2024 – In today’s fast-paced digital world, a robust social media presence is crucial for businesses, influencers, and content creators aiming to make a significant impact. Eagle Likes, a premier social media engagement service provider, is proud to offer a suite of comprehensive solutions to boost visibility, credibility, and audience interaction across leading social platforms. With a focus on organic growth, Eagle Likes provides services tailored to the needs of individuals and businesses alike.

Comprehensive Social Media Solutions

Eagle Likes understands the power of numbers in the social media ecosystem. Whether you’re aiming to increase your follower count, amplify post engagement, or expand your reach, Eagle Likes offers customized solutions that cater to various platforms. By leveraging our services, clients can enhance their social proof and credibility, enabling them to connect with a broader, more engaged audience.

Our services span across multiple social platforms, including:

  • YouTube: Boost your channel’s performance with our services for YouTube subscribers, YouTube views, YouTube likes, and YouTube watch time.
  • Instagram: Increase your Instagram followers, Instagram likes, and Instagram views to ensure your content gets the attention it deserves.
  • TikTok: Maximize your TikTok presence with TikTok followers, TikTok likes, TikTok views, and even TikTok shares, ensuring your videos go viral.
  • Facebook: From Facebook page likes to post interactions and video views, our Facebook services help grow your community and drive engagement.
  • Twitter: Elevate your Twitter game with services for Twitter followers, Twitter retweets, Twitter likes, Twitter views, and Twitter impressions.

Eagle Likes prides itself on offering real, high-quality social media engagement that fosters long-term growth and genuine connections with your audience.

Visit EagleLikes today to explore our full range of services.

Why Choose Eagle Likes?

  1. High-Quality Engagement: Eagle Likes guarantees that all interactions—whether likes, followers, or views—come from real users, ensuring authenticity and credibility.
  2. Platform Diversity: With services tailored for YouTube, Instagram, TikTok, Facebook, and Twitter, we cater to the unique requirements of different social platforms.
  3. Results-Driven Approach: Whether you’re a content creator looking to grow your following or a business aiming to increase brand visibility, our services are designed to deliver measurable, impactful results.
  4. Quick Delivery: Eagle Likes ensures that results are delivered in a timely manner without compromising on quality.
  5. Safe & Secure: We take your privacy and security seriously, offering services that comply with the guidelines of each social media platform.

How It Works

Getting started with Eagle Likes is simple. Visit https://www.eaglelikes.com and choose the social media platform you want to grow. Select the desired service, whether it’s YouTube watch time, Instagram followers, TikTok shares, or any of our other offerings. Our team will start delivering the engagement you need promptly, allowing you to focus on creating great content while we handle the growth.

About Eagle Likes

Eagle Likes is a UK-based social media engagement company, committed to providing tailored growth solutions for content creators, influencers, and businesses across the globe. Our mission is to help our clients enhance their digital presence with services that drive genuine audience engagement, boost visibility, and increase credibility.

Media Contact

Organization: Acentra Health

Contact Person: Ponnarasan Krishnan

Website: https://scholar.google.com/citations?hl=en&user=V8hc5RoAAAAJ

Email: Send Email

Country: United States

Release Id: 23102418805

The post Eagle Likes Launches Cutting-Edge Social Media Growth Services to Boost Online Visibility for Content Creators and Businesses appeared on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it.

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST

Like Us
Follow Us
Subscribe Us
Follow Us